Fig. 2From: Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trialTFRD in cohort 1. TFRD among (a) all patients who had recurrent disease and (b) patients who received chemotherapy after the development of recurrent diseaseBack to article page